Oral mucocutaneous allergies Flashcards
(46 cards)
Define allergy
When the immune system responds in an exaggerated or inappropriate way to an extrinsic (non-self) antigen
Define autoimmunity
When the immune system responds in an exaggerated or inappropriate way to an intrinsic (self) antigen
Define hypersensitivity
When the immune system responds in an exaggerated or inappropriate way resulting in harm
i.e. allergy & autoimmunity are both forms of hypersensitivity
When does hypersensitivity occur? (2)
Occurs on second exposure to the antigen
Hypersensitivity is a characteristic of the individual (genetic factors involved)
Hypersensitivity types (4)
Type I - Immediate/ anaphylaxis
Type II - Cytotoxic
Type III - Immune complex
Type IV - Delayed
Examples of all 4 may occur in the dental setting
Types 1-3 antibody mediated, type 4 cell mediated
Type I hypersensitivity (3)
Acute hypersensitivity/ anaphylaxis
Rapid onset
IgE mediated
Allergen - type I hypersensitivity (3)
Is an antigen (Ag) that give rise to Type 1 Hypersensitivity reactions
Most allergens are small (10-40 kDa) proteins
Examples:
-Der p 1&2 - dust mite faeces
-pollen - grass
Mast cell degranulation (1)
Histamine and enzyme release (Tryptase & Chymase)
Histamine release in type 1 hypersensitivity causes (5)
Increased Vascular dilatation (vasodilation) Vascular permeability i.e. oedema Bronchospasm Urticarial rash Increased asal and lacrimal secretions
Type 1 hypersensitivity most commonly presents as (3)
Hay fever Asthma Acute allergic responses: Angio-oedema / Anaphylaxis e.g -penicillin allergy -latex allergy -local anaesthetic allergy
Diagnosis for type 1 hypersensitivity (5)
Wheel and flare skin test
Apply small amount of Allergen just under skin using prick test.
Skin response is fast (5 min)
WHEEL caused by extravasation of serum into skin due to histamine – angio-odema.
FLARE (erythematous red patch) caused by axon reflex.
Late Phase (6 h+) due to leukocyte infiltrate + more oedema
Management of type 1 hypersensitivity (4)
Adrenaline (epinephrine)
Anti-histamines
Corticosteroids (e.g. dexamethasone)
Avoidance of allergen
Type 2 hypersensitivity (4)
Antibody-mediated hypersensitivity
Antibodies target self antigens (auto-antibodies)
Usually IgG or IgM
The antibodies induce cell damage and inflammation
Type 2 hypersensitivity: what happens (3)
Antibodies target self antigen (auto-antibodies)
Autoantibodies activate either: ADCC (antibody-dependent cell cytotoxicity) or complement
Complement activation results in inflammation, cell death (membrane attack complex)
Type 2 hypersensitivity responses in (2)
Acute transplant rejection (Host vrs Graft)
Autoimmune diseases e.g. pemphigus, pemphigoid
What is type 3 hypersensitivity (1)
Immune complex mediated hypersensitivity
Type 3 hypersensitivity - immune complexes form between (2)
Antigen and antibodies
Type 3 hypersensitivity - immune complexes may deposit in (3) where they induce (2)
The lining of blood vessels
Glomeruli
Lung
Induce complement activation and neutrophil binding –> inflammation and vascular permeability
Immune complex mediated hypersensitivity is important in (3)
Immune complex mediated vasculitis e.g. erythema multiforme, systemic lupus erythematous (SLE)
Type 4 hypersensitivity features (5)
Cell mediated immunity/ delayed type hypersensitivity Mediated by T cells Cellular response, so usually: -slow to develop -slow to resolve -localised
Cell mediated immune responses are important in (4)
Delayed type hypersensitivity responses
Contact dermatitis
Lichenoid reactions to amalgam fillings and other materials
Oral Lichen Planus (OLP)
Cells in oral lichen planus (3)
CD1
Langerhan’s cells
This stimulates the Langerhan’s cells to migrate to the draining lymph nodes
The antigen also stimulates the keratinocytes to release TNF
*****
Draining lymph node (5)
The Langerhan’s cells process the antigen
And present parts of it to T cells circulating through the lymph node
Antigen specific T cells become activated
Proliferate (clonal expansion)
And preferentially re-circulate to the oral mucosa
T cells and PMN pathway (8)
Oral mucosa
TNF incduces VCAM-1 expression on endothelium
Chemokines recruit T cells to oral epithelium (CCL5 [rantes])
ICAM-1 expression on oral keratinocytes allows T cells to bind to basal keratinocytes
This stimulates keratinocyte ICAM-1 (and MHC class II) expression
And then migrate between them
ICAM-1 & HLA II enables the keratinocytes to present antigen to the T cells, resulting in local
-activation of antigen specific T cells
-proliferation of antigen specific T cells
Cytotoxic T cells (CD8) kill basal keratinocytes (apoptosis)